No change in circulating osteoprotegerin levels by intravenous calcitriol therapy among dialysis patients with secondary hyperparathyroidism

Clin Nephrol. 2006 Feb;65(2):149-50. doi: 10.5414/cnp65149.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Calcitriol / analogs & derivatives*
  • Calcitriol / therapeutic use
  • Enzyme-Linked Immunosorbent Assay
  • Glycoproteins / blood*
  • Humans
  • Hyperparathyroidism, Secondary / drug therapy*
  • Osteoprotegerin
  • Receptors, Cytoplasmic and Nuclear / blood*
  • Receptors, Tumor Necrosis Factor / blood*
  • Renal Dialysis*
  • Treatment Outcome

Substances

  • Glycoproteins
  • Osteoprotegerin
  • Receptors, Cytoplasmic and Nuclear
  • Receptors, Tumor Necrosis Factor
  • TNFRSF11B protein, human
  • Calcitriol
  • maxacalcitol